Lacotab 100 Tablet contains Lacosamide 100 mg, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing the slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency and severity. Lacotab 100 is typically administered orally, with dosing individualized based on clinical response and tolerability. It may be used as monotherapy or adjunctive therapy in adults and pediatric patients aged four years and older. Common adverse effects include dizziness, headache, nausea, and fatigue, which are generally mild to moderate and transient. Caution is advised in patients with cardiac conduction abnormalities, as Lacosamide can prolong PR interval; baseline and periodic ECG monitoring may be warranted. Lacotab 100 should be used under strict medical supervision, with consideration of potential drug interactions, especially with other antiepileptic drugs and medications affecting cardiac conduction. Proper adherence to prescribed dosing regimens enhances therapeutic outcomes and minimizes risks. This medication is contraindicated in individuals with known hypersensitivity to Lacosamide or any excipients.